As for NOD1 and GZMA, the former exerted its antitumor effect on HCC by inhibiting SRC-MAPK axis and the latter interacted with F2R to suppress the activation of HCC cells [43, 44]. The gene discussed is SRC; the disease is hepatocellular carcinoma.